Cristina Larkin
2021
In 2021, Cristina Larkin earned a total compensation of $1.9M as Former Chief Operating Officer at Spero Therapeutics, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,107 |
|---|---|
| Option Awards | $848,983 |
| Salary | $460,406 |
| Stock Awards | $399,994 |
| Other | $9,440 |
| Total | $1,903,930 |
Larkin received $849K in option awards, accounting for 45% of the total pay in 2021.
Larkin also received $185.1K in non-equity incentive plan, $460.4K in salary, $400K in stock awards and $9.4K in other compensation.
Rankings
In 2021, Cristina Larkin's compensation ranked 6,219th out of 12,415 executives tracked by ExecPay. In other words, Larkin earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,219 out of 12,415 | 50th |
Division Manufacturing | 2,635 out of 5,505 | 52nd |
Major group Chemicals And Allied Products | 1,152 out of 2,375 | 52nd |
Industry group Drugs | 1,024 out of 2,096 | 51st |
Industry Pharmaceutical Preparations | 742 out of 1,546 | 52nd |
Source: SEC filing on August 5, 2022.
Larkin's colleagues
We found three more compensation records of executives who worked with Cristina Larkin at Spero Therapeutics in 2021.